300601.SZ SHZ
Shenzhen Kangtai Biological Products Co., Ltd.
1W: +3.8%
1M: +7.0%
3M: +15.8%
YTD: -11.7%
1Y: -21.6%
3Y: -47.1%
5Y: -84.8%
¥13.58 ($2.03)
+0.79 (+6.18%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$14.6B
-3.5% ▼
5Y CAGR: +29.8%
Total Liabilities
$4.9B
-11.6% ▼
5Y CAGR: +32.6%
Shareholders Equity
$9.7B
+1.3% ▲
5Y CAGR: +28.5%
Cash & Investments
$433M
-75.4% ▼
5Y CAGR: -3.0%
Total Debt
$1.8B
-25.1% ▼
5Y CAGR: +48.0%
Net Debt
$1.4B
+12.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $883M | $3.5B | $1.0B | $1.2B | $433M |
| Short-Term Investments | $2.2B | $0 | $441M | $563M | $0 |
| Cash & ST Investments | $3.0B | $3.5B | $1.5B | $1.8B | $433M |
| Net Receivables | $1.7B | $1.9B | $2.3B | $2.8B | $2.8B |
| Inventory | $437M | $1.1B | $728M | $773M | $783M |
| Other Current Assets | $257M | $742M | $574M | $76M | $2.2B |
| Total Current Assets | $5.3B | $7.3B | $5.2B | $5.4B | $6.2B |
| Property, Plant & Equip. | $2.3B | $4.1B | $5.2B | $5.7B | $5.2B |
| Goodwill & Intangibles | $367M | $736M | $475M | $504M | $534M |
| Long-Term Investments | $123M | $99M | $2.0B | -$463M | $1.7B |
| Other Non-Current Assets | $769M | $1.3B | $211M | $3.3B | $171M |
| Total Non-Current Assets | $4.2B | $6.8B | $8.6B | $9.7B | $8.3B |
| Total Assets | $9.6B | $14.1B | $13.8B | $15.1B | $14.6B |
| — Liabilities — | |||||
| Accounts Payable | $167M | $708M | $434M | $791M | $848M |
| Short-Term Debt | $11M | $778M | $274M | $60M | $34M |
| Deferred Revenue | $1.6B | $1.1B | $31M | $0 | $0 |
| Other Current Liabilities | $12M | $25M | $1.6B | -$12M | $223M |
| Total Current Liabilities | $1.8B | $2.6B | $2.3B | $2.8B | $2.6B |
| Long-Term Debt | $68M | $1.9B | $2.0B | $2.4B | $1.8B |
| Other Non-Current Liab. | $0 | $35M | $36M | $393M | $187M |
| Total Non-Current Liabilities | $365M | $2.4B | $2.5B | $2.8B | $2.3B |
| Total Liabilities | $2.1B | $5.0B | $4.8B | $5.5B | $4.9B |
| — Equity — | |||||
| Common Stock | $685M | $687M | $1.1B | $1.1B | $1.1B |
| Retained Earnings | $1.4B | $2.4B | $1.6B | $2.2B | $2.2B |
| Accumulated OCI | $1.8B | $2.4B | $3.0B | $3.1B | $3.3B |
| Total Stockholders Equity | $7.5B | $9.2B | $9.0B | $9.5B | $9.7B |
| Total Liabilities & Equity | $9.6B | $14.1B | $13.8B | $15.1B | $14.6B |
| — Key Metrics — | |||||
| Total Debt | $91M | $2.7B | $2.3B | $2.4B | $1.8B |
| Net Debt | -$792M | -$811M | $1.3B | $1.2B | $1.4B |
| Total Investments | $2.2B | $99M | $2.5B | $100M | $1.7B |